XKEMQ.PK.

[waxweazle]

Hi

Xkem looks good builded a Bottom Bolling-Bands tigthed up ! lokking good for a rally soon!
ON June the lunch of the Sick MEdicament will lunch the company tells.

Today Broken the 200 DMA

50 dma is now above 200 DMA

[investor2005dd]

when is the fda thingy going to be done?

[waxweazle]

when is the fda thingy going to be done?

In the last Q they tell as tehy will launch the product in June

[investor2005dd]

i think this thing will run soon....hopefully it will wipe out all my losses that I accumulated from my first year trading. Crossing my fingers here. If they could get approval by FDA, what pps do you see at the end of summer?

[GatewayStocks]

Shestco brochure w/ Nicosan profile

http://shestco.org/5_tech_park/nicosan.pdf

[waxweazle]

Xkem looks hot today

[setravis]

Here was a 7 page thread running ,all it had to be was updated.
Traders around here insist on starting a new thread.I don't know why they have to have so many threads running on the same stock pick....

[setravis]

Notice......

http://www.3stocksonfire.org/trading/index.php?topic=3019.0

[waxweazle]

From Yesterday:

Cardima Receives FDA Market Clearance for New Surgical Ablation System
Thursday May 25, 9:00 am ET

REVELATION(R) Tx PMA Application Still Pending Before FDA





and when Xkem also become the Market Clearance wow this cold also fly




In the last day we got a higer Volume

[Lucas Scott]

Went vertical into the close. I put in an order to see if I could get in on a little pullback but there was no pullback. Maybe buy Monday if it shows continuation possibility.

[oicpecnoc]

Fly me to the moon.

Let me play among the stars...... 

I think thats how it goes.  Anyway, there is always more money made seeing something happen before it does.  Feels better than chasing. 

You just never know if companies with potential will make it, but there seems to be a lot of smoke here, and I am hoping to see some fire in the near future.  This is another one of those that might be a good idea to just conveniently forget that you have, and check up on it in a few years. 

[waxweazle]

Why this stock runs look here:


Xechem\'s Subsidiary -- Xechem Pharmaceuticals Nigeria -- Receives
N150 Million Naira ($1.2 Million) Loan from NEXIM Bank

NEW BRUNSWICK, N.J., Jun 01, 2006 (BUSINESS WIRE) -- Xechem
International, Inc. (XKEM) announced today that its Nigerian
subsidiary, Xechem Pharmaceuticals Nigeria Ltd. (Xechem Nigeria),
has successfully closed on a N150 Million Naira ($1.2 million) loan
from the Nigerian Export-Import (NEXIM) Bank. The loan has a three
year term, with a moratorium on repayment of principal during the
first year. Xechem International is neither a borrower nor a
guarantor under the loan facility in this transaction.

Proceeds Earmarked For Expanding

Production Facility For NICOSAN(TM) In Abuja

The money received by Xechem Nigeria is to be used primarily to
facilitate the expansion of its facility for the commercial scale
production of NICOSAN(TM), its promising Sickle Cell drug. At the
signing ceremony held at NEXIM\'s headquarters in Abuja, Nigeria, Dr.
Ramesh Pandey, Chairman and CEO of both Xechem International and
Xechem Nigeria, said, "The loan will enable the company to
immediately begin construction of buildings needed to expand its
commercial scale production facility in Abuja. It is a proud moment
not only for Xechem Nigeria, but for the whole of Nigeria as well.
By taking this giant step with us, NEXIM Bank has confirmed to the
world the great confidence it has in this project. This will not
only accelerate Xechem\'s efforts in bringing NICOSAN(TM) to the
market, but will also help build international esteem for Nigeria
and the changing investment climate in that country. We are
extremely gratified that we can now embark on our much needed
expansion, and are particularly excited that we can do so with
locally generated funds from a respected and reputable local bank."

The Chairman of NEXIM Bank, who is also Deputy Governor of Central
Bank of Nigeria, Mr. Tunde Lemo, complimented Xechem for coming to
Nigeria and setting up the facility to produce NICOSAN(TM) to treat
an African disease for which there is no drug in the market.

Speaking of the dignitaries in attendance at the signing ceremony,
Dr. Pandey added: "I am very pleased and happy to see Professor
A.B.C. Nwosu, the former Honorable Health Minister, at this
ceremony. It was during his tenure that Xechem obtained the
exclusive worldwide license for NICOSAN(TM) from the National
Institute for Pharmaceutical Research and Development (NIPRD). I am
also honored to see among those in attendance the Hon. Prof. Turner
Isoun, Nigeria\'s Minister of Science and Technology. From the
beginning, he has been extremely supportive of our efforts and we
are forever grateful for the interest he has taken in what we are
doing in Nigeria."

Among the other dignitaries present at the May 22nd signing ceremony
at NEXIM Bank building in Abuja were: MD & CEO of NEXIM Bank, Alhaji
Baba Yusuf Ahmed; The Minister of State for Finance (represented);
The Director General of Sheda Science & Technology, Dr. Ayo Coker;
Mr. Alhaji Tijani, Director General & CEO of Abuja Development
Corporation, representing The Chairman of the Federal Capitol of
Nigeria.

Drug To Be Launched In Nigeria Following NAFDAC Approval

As previously reported by Xechem International, Xechem Nigeria has
submitted its Drug Master File (DMF) dossier with Nigeria\'s drug
regulatory agency, the National Agency for Food and Drug
Administration and Control (NAFDAC), seeking full registration for
NICOSAN(TM). It is currently awaiting final word from that agency on
its submission. Subject to the necessary approvals, Xechem has
indicated that it would like to launch the drug in Nigeria by early
July 2006, and shortly thereafter to embark on the clinical trials
in the US hospitals for FDA approval through the Investigational New
Drug (IND) Application for sale of the drug in the United States.

About Xechem

Xechem International, Inc. is a development stage biopharmaceutical
company whose focus and resources are currently being primarily
directed toward the development and commercial launch of NICOSAN(TM)
(to be marketed as HEMOXIN(TM) in the United States and Europe),
which has shown efficacy in the prophylaxis management of Sickle
Cell Disease (SCD). Xechem is also working on anticancer, antiviral
(including AIDS), antifungal, antimalarial and antibacterial
products from natural sources, including microbial and marine
organisms. Xechem\'s mission is to bring relief to the millions of
people who suffer from these diseases. Its focus is on the
development of phyto-pharmaceuticals (Natural Herbal Drugs) and
other proprietary technologies, including those used in the
treatment of orphan diseases.

Forward Looking Statements

This press release contains certain forward looking statements
within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities and Exchange Act of 1934,
as amended, which are intended to be covered by safe harbors created
hereby. Such forward-looking statements involve known and unknown
risks and uncertainties.

SOURCE: Xechem International, Inc.

Xechem International, Inc.Stephen Burg, 707-425-8855

Copyright Business Wire 2006

[waxweazle]

[Ramsburg]

XKEM was on my filters today.

I'm not familiar with this stock, but the chart is interesting:

[Terliso]

A lot of good pennies over here

3 moving averages that i'm following 50SMA, 200SMA, 200EMA clustering together along with the price... breakout now!